Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
qGenEx Intellectual disability Quantitative Genomic Medicine Laboratories, SL Spain | 3 | 1969 |
|
Invitae Comprehensive Carrier Screen Invitae United States | 886 | 547 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins Hospital United States | 163 | 128 |
|
Genetic Services Laboratory University of Chicago United States | 3 | 16 |
|
Primary Ciliary Dyskinesia (PCD)/Immotile Cilia Syndrome Panel PreventionGenetics, part of Exact Sciences United States | 44 | 50 |
|
Invitae Primary Ciliary Dyskinesia Panel Invitae United States | 49 | 37 |
|
Primary Ciliary Dyskinesia (PCD) via the DNAI1 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
PreventionGenetics, part of Exact Sciences United States | 135 | 133 |
|
Primary Ciliary Dyskinesia (PCD)/Immotile Cilia Syndrome and Cystic Fibrosis Panel PreventionGenetics, part of Exact Sciences United States | 44 | 51 |
|
Primary ciliary dyskinesia (WES-based NGS panel of 34 genes, including analysis of CNVs) CGC Genetics Unilabs Portugal | 1 | 34 |
|
Cardiovascular Comprehensive Panel CGC Genetics Unilabs Portugal | 1 | 353 |
|
Congenital Heart Defects Panel CGC Genetics Unilabs Portugal | 1 | 208 |
|
CGC Genetics Unilabs Portugal | 1 | 107 |
|
CGC Genetics Unilabs Portugal | 1 | 178 |
|
Ciliary dyskinesia, primary 1 (deletion/duplication analysis of DNAI1 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Ciliary dyskinesia, primary 1 (sequence analysis of DNAI1 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Immunodeficiencies and Immunologic Diseases Panel (Complete) Mendelics Brazil | 1 | 397 |
|
Primary Ciliary Dyskinesia Panel Mendelics Brazil | 1 | 35 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.